Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 <scp>POETYK PSO</scp>‐1, <scp>PSO</scp>‐2 and long‐term extension trials
Deucravacitinib demonstrated a consistent safety profile and durable efficacy through 4 years of treatment in patients with moderate to severe plaque psoriasis.
Authors
- Matthew J. Colombo (ORCID: https://orcid.org/0009-0006-5653-381X)
- Kim Papp (ORCID: https://orcid.org/0000-0001-9557-3642)
- Victoria Berger (ORCID: https://orcid.org/0000-0003-4347-6140)
- Georgene Schroeder
- April Wang Armstrong (ORCID: https://orcid.org/0000-0003-0064-8707)
- Joe Zhuo (ORCID: https://orcid.org/0000-0003-3632-2418)
- Howard Sofen (ORCID: https://orcid.org/0000-0001-7789-6915)
- C. Paul (ORCID: https://orcid.org/0000-0003-0165-5263)
- Richard Bruce Warren (ORCID: https://orcid.org/0000-0002-2918-6481)
- Akimichi Morita (ORCID: https://orcid.org/0000-0001-8372-3754)
- Diamant Thaçi (ORCID: https://orcid.org/0000-0001-8513-550X)
- Julie Scotto
- Bruce E Strober (ORCID: https://orcid.org/0000-0002-8394-2057)
- Subhashis Banerjee (ORCID: https://orcid.org/0009-0000-1365-5207)
- John Vaile (ORCID: https://orcid.org/0000-0003-3540-0648)
- Eleni Vritzali
- Mark Lebwohl
Institutions
- Université Toulouse III - Paul Sabatier (FR)
- University of California, Los Angeles (US)
- University of Toronto (CA)
- Manchester Academic Health Science Centre (GB)
- Northern Health and Social Care Trust (GB)
- Yale University (US)
- Nagoya City University (JP)
- Bristol-Myers Squibb (United States) (US)
- Manchester University NHS Foundation Trust (GB)
- Probity Medical Research (CA)
- Hôpital Larrey (FR)
- Central Dermatology (US)
- NIHR Manchester Biomedical Research Centre (GB)
- University of Lübeck (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1111/jdv.20553
- Citations
- 18
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 14.35